CXCL13 Mab

N/A

Report date: 2024/11/26 17:30:44

Base Information

Drug NameCXCL13 Mab
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionC-X-C motif chemokine 13 inhibitors
TargetsC-X-C motif chemokine 13
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVaccinex Inc
China Registration ClassN/A

Develop Information

Active CompaniesVaccinex Inc
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A